Clinical Trial Update: Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)

View source ↗

Summary

A Cedars-Sinai trial is studying small intestinal bacterial overgrowth in pancreatic adenocarcinoma patients, and it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Pancreatic Adenocarcinoma, Weight Loss | Status: RECRUITING